iWallet 3Q 2026: Revenue $0, EPS ($0.00) — 10-Q Summary

iWallet reported no revenue for 3Q 2026, with a net loss of $204.32K, wider than the prior year's $185.51K. Operating expenses decreased due to lower R&D costs, but interest expenses increased, including a $83.155K derivative loss. The company focuses on biometric wallets and security products, according to its 10-Q filing.

Original reporting
Published Nov 16, 2026, 3:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 3:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
iWallet 3Q 2026: Revenue $0, EPS ($0.00) — 10-Q Summary — source image
Decision brief

The 30-second read

$IWALBearishLow
01

Why it matters

The key takeaway is that revenue remained at $0 while the net loss widened year over year, with the largest cited deterioration coming from higher interest expense tied to new notes, a day-one derivative loss, and debt discount amortization.

02

Market read

For IWAL, the filing provides a fresh quarterly datapoint on profitability and financing-related expense pressure, but it is not a guidance, deal, or regulatory catalyst.

03

What to watch

Traders may also want to separate cash burn versus non-cash derivative and discount amortization effects, which are not detailed in this summary.

Relevance 5/10Novelty 4/10Timing: filed Nov. 16, 2026, for the just-reported quarter

Background

The article is a brief summary of iWallet’s 10-Q for the quarter ended in 3Q 2026, focusing on revenue, net loss, and expense drivers.

Company-level read

Ticker impact

$IWALBearishMedium confidence
Context

iWallet reported 3Q 2026 revenue of $0 and a widened net loss, with interest expense rising due to day-one derivative loss and debt discount amortization.

Expected impact

Likely downward pressure as the market focuses on the worsening bottom line and financing/derivative cost burden.

Evidence & confidence

The filing summary highlights zero revenue and a larger net loss, with the main driver explicitly attributed to interest expense components that can recur with ongoing debt/derivatives.

Market effects

Limited read-through to the broader sector because the disclosure is company-specific and the revenue base is zero.

No clear regional spillover beyond small-cap microcap sentiment.

No meaningful global market linkage indicated.

Counterpoint

Lower R&D costs reduced operating expenses, suggesting some cost discipline, and the interest expense spike may be partly non-recurring derivative accounting.

Key entities

  • iWallet Corp

    US-listed issuer (IWAL) reporting 3Q 2026 results in a 10-Q summary, including $0 revenue and a widened net loss driven by interest expense.

Related articles

$XPMedAI 8/10

XP Q3 2026 slides: asset growth strong, but margin pressure evident

XP Inc. reported Q3 2026 earnings with total client assets up 15% YoY to R$2.2T, but net margins contracted to 26.9%. Revenue grew 8% YoY to R$5.3B, while SG&A expenses rose 12% YoY. Shares fell 4.26% post-earnings. The company is diversifying revenue, with non-investment revenues now 20% of retail revenue. Management expects 10% annual top-line growth in 2027.

$LUVUMed

Luvu Brands, Inc.: Luvu Brands Reports First Quarter Fiscal 2027 Results: 10% Net Sales Growth, Wholesale Sales Up 12%

Luvu Brands (LUVU) reported Q1 FY2027 results with net sales up 10% to $6.78M, wholesale sales up 12.3% to $4.72M, and direct-to-consumer sales up 5.3% to $2.06M. Gross profit fell 10.1% to $1.78M due to higher freight and labor costs, resulting in an operating loss of $332K and a net loss of $365K. Cash from operations increased to $120K, and cash reserves were $1.02M.